Opening Our Eyes To Stem Cells For Stargardt's Macular Dystrophy

Stem cell therapies are being studied in clinical trials to treat retinitis pigmentosa, a genetic disorder that causes vision loss.
Source: Forbes.com Healthcare News - Category: Pharmaceuticals Authors: Tags: Healthcare /healthcare Innovation /innovation business pharma & standard Source Type: news